Nano-X Imaging Aims to Disrupt Medical Imaging in Developing Markets, But Profitability Remains a Key Question
• Nano-X Imaging stock has risen 43% over the past year amid bullishness for AI and medical devices, but it's still early stages for the company.
• Nano-X aims to deploy imaging machines globally using a pay-per-scan model, targeting developing markets where upfront hardware costs are a barrier.
• If successful, Nano-X could generate significant recurring revenue from installed bases with low marginal costs.
• Financials are still weak as expected in early days, but improved profitability trends would bolster the bull case.
• It's risky now, but has disruptive potential if it succeeds with ambitions for overlooked markets. Wait for profitability signals before investing significantly.